Stifel Financial
ICPT

Stifel Financial’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Stifel Financial’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,264
Closed -$125K – 3432
2023
Q2 		$125K Buy
+11,264
New +$157K ﹤0.01% 3137
2022
Q3 		– Sell
-14,691
Closed -$203K – 3409
2022
Q2 		$203K Buy
14,691
+3,344
+29% +$53.5K ﹤0.01% 2991
2022
Q1 		$185K Buy
+11,347
New +$178K ﹤0.01% 3150
2021
Q1 		– Sell
-17,104
Closed -$422K – 3311
2020
Q4 		$422K Buy
17,104
+10,155
+146% +$337K ﹤0.01% 2426
2020
Q3 		$288K Sell
6,949
-577
-8% -$26.5K ﹤0.01% 2431
2020
Q2 		$361K Buy
+7,526
New +$581K ﹤0.01% 2232
2020
Q1 		– Sell
-2,698
Closed -$333K – 3138
2019
Q4 		$333K Sell
2,698
-2,144
-44% -$192K ﹤0.01% 2486
2019
Q3 		$322K Buy
+4,842
New +$325K ﹤0.01% 2408
2019
Q2 		– Sell
-2,329
Closed -$258K – 3074
2019
Q1 		$258K Buy
2,329
+61
+3% +$6.67K ﹤0.01% 2453
2018
Q4 		$228K Buy
+2,268
New +$235K ﹤0.01% 2392
2015
Q3 		– Sell
-1,193
Closed -$288K – 2396
2015
Q2 		$288K Sell
1,193
-35
-3% -$9.32K ﹤0.01% 1985
2015
Q1 		$347K Sell
1,228
-190
-13% -$41.1K ﹤0.01% 1820
2014
Q4 		$221K Buy
+1,418
New +$262K ﹤0.01% 2030

Other funds holding ICPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Stifel Financial's ICPT Position: Q3 2023 in Review

Stifel Financial sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2023, closing a stake of 11,264 shares — an estimated $125K sold.

Stifel Financial first reported a position in ICPT in Q4 2014 and held it in 13 quarters. The position peaked at $422K in Q4 2020. 146 funds tracked by Wall St. Rank hold ICPT as of Q3 2023.

  • Stifel Financial reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Stifel Financial sold 11,264 Intercept Pharmaceuticals, Inc. shares in Q3 2023, an estimated $125K.
  • Stifel Financial first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2014 and held it in 13 quarters.
  • Stifel Financial's Intercept Pharmaceuticals, Inc. position peaked at $422K in Q4 2020.
  • 146 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2023.

Based on Stifel Financial's 13F filing for Q3 2023, filed 13 Nov 2023.